Instil Bio eyes key NSCLC catalyst with Phase 2 China data in 2H 2025 and a distinct U.S. strategy. Learn why AXN-2510 stands ...

In 1992, graduate student Yasumasa Ishida discovered PD-1, marking the beginning of a journey that would make this molecule a ...

Ivonescimab helped cut the risk of lung tumor progression in half in a multi-country Phase 3 trial. But it hasn’t yet clearly ...

Incyte's first attempt to get FDA approval for its PD-1 inhibitor Zynyz for squamous cell carcinoma of the anal canal (SCAC) was knocked back by the FDA, but new data could get the programme back ...

Molecular characterization of an extensive lung cancer patient-derived xenograft (PDX) resource.

Recent breakthroughs in understanding the prostaglandin D2 (PGD2) receptor 1 (DP1) are paving the way for innovative ...

Commercialization building with large pharma contracts securedFurther progress on next generation sequencing assays for DNA dual analysis of CTC-DNA and ctDNA GUILDFORD, UNITED KINGDOM / ACCESS ...

Researchers have captured a time-resolved video of a protein interaction essential to healthy brain development.